Suchergebnisse - "Şentürk Öztaş, Nihan"

PubPharm (9)

1

Effect of antibiotic treatment on immune checkpoint inhibitors efficacy in patients with advanced non-small cell lung cancer

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2023

von Alkan Şen, G. | Şentürk Öztaş, N. | Değerli, E. | +3

2

Relationship between pathological response and molecular subtypes in locally advanced breast cancer patients receiving neoadjuvant chemotherapy

enthalten in: Journal of chemotherapy (Florence, Italy) | 2023

von Değerli, E. | Şentürk Öztaş, N. | Alkan, G. | +8

3

External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) : Results From the Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database

enthalten in: Clinical genitourinary cancer | 2023

von Yekedüz, E. | Karakaya, S. | Ertürk, �. | +18

4

Clinical Features and Prognostic Factors of Metastatic Non-Clear Cell Renal Cell Carcinoma : A Multicenter Study from the Turkish Oncology Group Kidney Cancer Consortium

enthalten in: Urologia internationalis | 2023

von Erol, C. | Yekedüz, E. | Tural, D. | +15

5

The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond : a Turkish oncology group kidney cancer consortium (TKCC) study

enthalten in: Journal of cancer research and clinical oncology | 2022

von Yekedüz, E. | Tural, D. | Ertürk, �. | +13

6

The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: a Turkish oncology group kidney cancer consortium (TKCC) study

enthalten in: Journal of cancer research and clinical oncology | 2022

von Yekedüz, E. | Tural, D. | Ertürk, �. | +13

7

The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: a Turkish oncology group kidney cancer consortium (TKCC) study

enthalten in: Journal of cancer research and clinical oncology | 2022

von Yekedüz, E. | Tural, D. | Ertürk, �. | +13

8

The demographic characteristics, prognosis, and relationship with cancer subtypes of hospitalized COVID-19 patients with malignancy : A single-center experience

enthalten in: Journal of medical virology | 2021

von Değerli, E. | Derin, S. | Oruç, K. | +7

9

The demographic characteristics, prognosis, and relationship with cancer subtypes of hospitalized COVID‐19 patients with malignancy : A single‐center experience

enthalten in: Journal of Medical Virology | 2021

von Değerli, E. | Derin, S. | Oruç, K. | +7

1
[1]